
CERUS CORP
Nasdaq · Surgical & Medical Instruments & Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
Cerus Corporation develops and markets blood safety technologies, including its INTERCEPT Blood System, which uses photochemical treatment to reduce pathogens in donated blood components such as platelets, plasma, and red blood cells for use by blood centers and hospitals.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Jensen ChrystalChief Legal Officer | Sell | $90K | 30,000at $2.98 | Aug 17, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CERS activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.